Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T17:03:14.548Z.
Calculation as of: 2026-10-06T17:03:14.548Z.
Quote observation: 2026-10-06T17:00:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 69a1d57d3f318828ebe19021960b74268097702d5d6050a421f3255bba496414
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
MoonLake Immunotherapeutics
Market Cap
$939.15M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$948.56M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$950.77M
Operating Cash Flow Yield
N/A
TTM Avg
16.88%
3Y Avg
16.91%
5Y Avg
16.91%
Market Cap
$917.90M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$915.21M
Operating Cash Flow Yield
7.84%
TTM Avg
8.82%
3Y Avg
7.69%
5Y Avg
7.20%
Market Cap
$968.36M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$979.53M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | $939.15M | N/A | N/A | N/A | N/A |
| CeriBell, Inc. (CBLL)vs › | $931.25M | N/A | N/A | N/A | N/A |
| Seaport Therapeutics, Inc. Common Stock (SPTX)vs › | $948.56M | N/A | N/A | N/A | N/A |
| Kura Oncology, Inc. (KURA)vs › | $950.77M | N/A | 16.88% | 16.91% | 16.91% |
| Savara Inc. (SVRA)vs › | $953.94M | N/A | N/A | N/A | N/A |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $917.90M | N/A | N/A | N/A | N/A |
| HealthStream, Inc. (HSTM)vs › | $915.21M | 7.84% | 8.82% | 7.69% | 7.20% |
| Aktis Oncology, Inc. (AKTS)vs › | $968.36M | N/A | N/A | N/A | N/A |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $979.53M | N/A | N/A | N/A | N/A |
| MeiraGTx Holdings plc (MGTX)vs › | $979.81M | 1.40% | 0.99% | 0.99% | 0.99% |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
